• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT ¿; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911316350
Device Problems Occlusion Within Device (1423); Device Operates Differently Than Expected (2913)
Patient Problems Calcium Deposits/Calcification (1758); Congestive Heart Failure (1783); Death (1802); Reocclusion (1985)
Event Date 07/27/2015
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2015-07725, 2134265-2015-07726.(b)(6) clinical study.It was reported that the patient died.The index procedure was performed on (b)(6) 2012.The 90%stenosed target lesion, 3.5x10mm, de novo, eccentric, type b2 coronary lesion with a =< 45 degree bend and timi 3 flow, and was located in the severely calcified and moderately tortuous mid right coronary (rca) artery.The physician treated the lesion with pre-dilatation and placement of a 3.5x16mm promus element stent at 12 atmospheres.Following post dilatation, residual stenosis was 0% with timi 3 flow.Target lesion # 2 was a 90% stenosed target lesion, 3.0x15mm, de novo, eccentric, type b2 coronary lesion with a =< 45 degree bend and timi 3 flow, and was located in the severely calcified and moderately tortuous mid of distal rca artery.Target lesion #2 was treated with pre-dilatation and placement of a 3.0x28mm promus element stent at 12 atmospheres.Following post dilatation, residual stenosis was 0% with timi 3 flow.Target lesion # 3 was a 90% stenosed target lesion, 3.0x15mm, de novo, eccentric, type b2 coronary lesion with a =< 45 degree bend and timi 3 flow, and was located in the severely calcified and moderately tortuous distal rca artery.Target lesion #3 was treated with pre-dilatation and placement of a 3.0x28mm promus element stent at 12 atmospheres.Following post dilatation, residual stenosis was 0% with timi 3 flow.One post procedure, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2015, the patient developed congestive heart failure.Medication was given and angiography was performed and revealed isr in the previously implanted stent in the mid rca.In (b)(6) 2015, the patient died due to congestive heart failure.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that in (b)(6) 2015, in-stent restenosis (isr) was noted in the previously implanted 3.50x16mm promus element stent in mid right coronary artery (rca).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT ¿
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5235884
MDR Text Key31608474
Report Number2134265-2015-07724
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/23/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberH7493911316350
Device Catalogue Number39113-1635
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/23/2015
Initial Date FDA Received11/19/2015
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received11/20/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age72 YR
Patient Weight74
-
-